In this interview, we discuss the current state of therapies available in treating CML patients and the role of newer agents.
Michael Mauro, MD
Advertisement
Articles by Michael Mauro, MD
Advertisement
Latest Updated Articles
State of CML TreatmentsJuly 25th 2013
Advertisement
Advertisement
Trending on CancerNetwork
1
Melanoma Trials You May Have Missed at ASCO 2026
2
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
3
75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings
4
Subcutaneous Isatuximab Earns EU Approval in Multiple Myeloma
5